A detailed history of West Coast Financial LLC transactions in Novartis Ag stock. As of the latest transaction made, West Coast Financial LLC holds 3,084 shares of NVS stock, worth $320,150. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,084
Previous 3,084 -0.0%
Holding current value
$320,150
Previous $328,000 7.93%
% of portfolio
0.04%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$92.57 - $107.37 $4,073 - $4,724
-44 Reduced 1.41%
3,084 $328,000
Q1 2024

Apr 12, 2024

BUY
$95.27 - $108.47 $190 - $216
2 Added 0.06%
3,128 $302,000
Q4 2023

Jan 11, 2024

SELL
$92.27 - $101.54 $18,454 - $20,308
-200 Reduced 6.01%
3,126 $315,000
Q1 2023

May 08, 2023

SELL
$80.03 - $92.81 $32,012 - $37,124
-400 Reduced 10.74%
3,326 $305,000
Q3 2022

Oct 31, 2022

SELL
$74.61 - $87.26 $12,310 - $14,397
-165 Reduced 4.24%
3,726 $283,000
Q2 2022

Jul 11, 2022

SELL
$80.52 - $93.75 $3,623 - $4,218
-45 Reduced 1.14%
3,891 $329,000
Q4 2021

Jan 19, 2022

BUY
$79.7 - $88.13 $28,771 - $31,814
361 Added 10.1%
3,936 $344,000
Q3 2021

Nov 03, 2021

BUY
$81.78 - $95.14 $12,348 - $14,366
151 Added 4.41%
3,575 $292,000
Q2 2021

Jul 28, 2021

SELL
$85.24 - $94.15 $8,864 - $9,791
-104 Reduced 2.95%
3,424 $312,000
Q1 2021

May 10, 2021

SELL
$83.5 - $98.47 $29,893 - $35,252
-358 Reduced 9.21%
3,528 $302,000
Q3 2020

Nov 05, 2020

SELL
$82.14 - $91.0 $5,749 - $6,370
-70 Reduced 1.77%
3,886 $338,000
Q1 2020

Apr 21, 2020

SELL
$70.67 - $99.01 $17,667 - $24,752
-250 Reduced 5.94%
3,956 $326,000
Q3 2019

Oct 16, 2019

BUY
$85.54 - $94.26 $35,755 - $39,400
418 Added 11.03%
4,206 $366,000
Q2 2019

Jul 16, 2019

SELL
$75.4 - $92.8 $22,620 - $27,840
-300 Reduced 7.34%
3,788 $346,000
Q4 2018

Jan 29, 2019

SELL
$73.66 - $82.02 $42,133 - $46,915
-572 Reduced 12.27%
4,088 $351,000
Q3 2018

Oct 19, 2018

SELL
$66.94 - $77.43 $1,137 - $1,316
-17 Reduced 0.36%
4,660 $402,000
Q2 2018

Jul 16, 2018

SELL
$64.91 - $73.36 $111,645 - $126,179
-1,720 Reduced 26.89%
4,677 $353,000
Q1 2018

Apr 17, 2018

SELL
$70.39 - $84.15 $18,301 - $21,879
-260 Reduced 3.91%
6,397 $517,000
Q4 2017

Jan 19, 2018

SELL
$72.33 - $77.64 $123,322 - $132,376
-1,705 Reduced 20.39%
6,657 $559,000
Q3 2017

Nov 02, 2017

BUY
$74.14 - $77.27 $619,958 - $646,131
8,362
8,362 $718,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track West Coast Financial LLC Portfolio

Follow West Coast Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Coast Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Coast Financial LLC with notifications on news.